Market Overview

Fluidigm, Genome Institute of Singapore Establish Asia's First Single-Cell Genomics Research Center

The Genome Institute of Singapore (GIS), an institute under the umbrella
of the Agency for Science, Technology and Research (A*STAR), and
Fluidigm Corporation (NASDAQ: FLDM) announced Friday, the establishment of
the first research center in Asia exclusively dedicated to accelerating
the understanding of how individual cells work, and how diagnosis and
treatment might be enhanced through insight derived from single cells.
The GIS-Fluidigm Single-Cell ‘Omics Center (SCOC) is expected to act as
a focal point for collaborative efforts among single-cell genomics
researchers across the region.

The SCOC will be a visionary academic-industry partnership designed to
provide integrated analytics for single-cell genomic applications to the
region's researchers. This interdisciplinary center will bring

See full press release

Posted-In: Earnings News Guidance Contracts Management Global

 

Related Articles (FLDM)

Around the Web, We're Loving...

Get Benzinga's Newsletters